UCB

UCB

Pharmaceutical Manufacturing

Inspired by patients. Driven by science.

About us

UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2023 Key Financials: € 5.3 billion global revenue Specialties: Neurology, Immunology

Website
http://www.ucb.com
Industry
Pharmaceutical Manufacturing
Company size
5,001-10,000 employees
Headquarters
Brussels
Type
Privately Held
Founded
1928
Specialties
Neurology, Immunology, and Healthcare Innovation Beyond Medicine

Locations

Employees at UCB

Updates

Similar pages

Funding

UCB 3 total rounds

Last Round

Post IPO equity

US$ 101.4M

See more info on crunchbase